Migraine-treatment company Theranica picks up $45m Series CNew Rhein Healthcare Investors led the round.ByIris Dorbian31 August 2022•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.IsraelMiddle East / North AfricaNorth AmericaUSDeals & ExitsBriefs